Biotech entity

NVIDIA

Company NVDA

pharma is the sole category represented across all 3 tracked stories. The 8 average consequence score is above the beat benchmark of 6.1 in the same window. They are less corroborated than the beat average, carrying 2 original sources each against 3.7 for the same window.

Last mentioned: 9m ago

Entity pulse

Recent coverage · NVIDIA

3 stories
8 avg impact
67% positive
33% negative

Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 34 percentage points.

  • 67% positive
  • 33% negative

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about NVIDIA

pharma is the sole category represented across all 3 tracked stories. The 8 average consequence score is above the beat benchmark of 6.1 in the same window. They are less corroborated than the beat average, carrying 2 original sources each against 3.7 for the same window. AI Lung Digital Twin Platform is the most frequent co-covered peer, appearing in 1 of the 3 tracked stories. Across a 12-day span, the pace is roughly 1.8 stories per week. This profile follows 3 Biotech stories mentioning NVIDIA across the period from March 7, 2026 to March 18, 2026.

Stories tracked
3
Per week
1.8
Sources per story
2

Computed from the 3 stories linked to this entity, with beat comparisons drawn from all 165 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering NVIDIA. Shared-story counts are live from our verified record — not editorial picks.

Key Data

ticker
NVDA
name
Nvidia
price
215.5
change
5.3
changePct
2.56

Timeline

  1. Therapeutic Discovery

    Anticipated identification of first novel therapeutic leads derived from the Atlas.

  2. Model Training

    Initial training of trillion-parameter biological models on NVIDIA infrastructure.

  3. Data Collection Expansion

    Scaling of field operations to thousands of global sites for species sampling.

  4. Official Launch

    Basecamp Research announces the Trillion Gene Atlas initiative and core partnerships.

Stories mentioning NVIDIA 3

Pharma Negative

Geopolitical Conflict in Middle East Threatens Global Pharma Supply Chains

The escalating conflict between the U.S., Israel, and Iran has paralyzed the Strait of Hormuz, causing a surge in energy prices and disrupting critical trade routes. For the pharmaceutical industry, this geopolitical instability threatens the global supply of raw materials and increases the cost of temperature-controlled logistics.

2 sources

NVIDIA is linked from 3 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.